New immune therapy to help recovery after brain injuries
Novel immune therapy to promote functional recovery after traumatic brain injury
This study is exploring a new treatment that helps the immune system heal the brain after a traumatic injury, and it's looking for people with brain injuries to see if this therapy can help them recover better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Veterans Health Administration NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10950305 on NIH RePORTER |
What this research studies
This research investigates a novel immune therapy aimed at enhancing recovery from traumatic brain injury (TBI). It focuses on understanding how specific immune cells, particularly regulatory T cells, can be activated to reduce inflammation and promote brain repair. By studying the interactions between these immune cells and the brain's response to injury, the research aims to identify new therapeutic targets that could lead to improved outcomes for individuals suffering from TBI. Patients may be involved in trials that assess the effectiveness of this therapy in promoting functional recovery.
Who could benefit from this research
Good fit: Ideal candidates for participation are adults aged 21 and older who have experienced a traumatic brain injury.
Not a fit: Patients with chronic neurological conditions unrelated to traumatic brain injury may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that significantly improve recovery and quality of life for patients with traumatic brain injuries.
How similar studies have performed: Previous studies have shown promise in using immune modulation for neuroprotection in stroke, suggesting potential for success in similar approaches for TBI.
Where this research is happening
Pittsburgh, United States
- Veterans Health Administration — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Hu, Xiaoming — Veterans Health Administration
- Study coordinator: Hu, Xiaoming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.